Transgenic mice containing the human renin gene were constructed with the aim of examining the tissueand cell-specific expression of human renin. The human renin transgene used consisted of a genomic sequence extending approximately 900 bp upstream and 400 bp downstream of the coding region and included all exon and intron sequences. Two assays were developed to differentiate human renin transcripts from endogenous mouse renin transcripts at the whole-tissue level. High level human renin expression was evident in the kidney, adrenal gland, ovary, testis, lung, and adipose tissue of all four transgenic lines examined. Human renin mRNA could also be detected at lower levels in the submandibular gland and heart of two different individual lines. No expression was evident in the liver or brain of any line tested. In situ hybridization revealed the human renin mRNA to be localized and exquisitely restricted to renal juxtaglomerular cells. Treatment of transgenic mice with captopril resulted in an increase in the accumulation of renal renin mRNAs derived from both the mouse and human renin genes.
T he renin-angiotensin system plays an integral part in blood pressure and electrolyte regulation in mammals and is thought to play a role in the pathophysiology of some forms of hypertension. Although the site primarily responsible for plasmaborne active renin is the kidney, renin and/or renin mRNA has also been reported in reproductive tissues, in the adrenal gland, and, at lower levels, in a number of other tissues. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] Renin expression in several of these tissues is evolutionarily conserved, suggesting that its expression at these sites may be functionally important. 15 Indeed, a number of provocative proposals have been made regarding the function of extrarenal renin, although definitive proof of function remains to be demonstrated.916-'9 Several laboratories have extensively characterized the tissueand cell-specific expres-sion profile of mouse and rat renin.135,61520-22 These studies have revealed that there are significant differences in the expression of renin between rodent species and even within different mouse strains and subspecies.1351523 Less detailed information is available regarding the expression of human renin mRNA. Since we cannot predict a priori the tissue specificity of the human renin gene based completely on expression of mouse or rat renin, a direct assessment of human renin gene expression needs to be undertaken.
Transgenic mice provide an excellent opportunity to examine the expression of heterologous species genes in an experimentally amenable system. Previous studies have shown that the tissue and cell specificity of interspecific genes is faithfully conserved in transgenic mice; and patterns of expression unique to those species are also often conserved. 24, 25 The latter is particularly important for studies on the human renin gene because of species-specific differences in the tissue distribution and cellular localization of renin. For example, renin is expressed in the submandibular gland in mice but not in rats, 22, 26 and adrenal renin in mice is localized to the zona fasciculata and X zone, whereas in rats it has been reported in the zona glomerulosa. 2728 In this article we report our analysis of human renin gene expression in transgenic mice. The transgene we chose for this analysis contains all exon and intron sequences and upstream and downstream flanking se-quences extending approximately 900 bp upstream (5' of the gene) and 400 bp downstream (3' in the gene). Our results demonstrate that this transgene is expressed in a tissue-specific manner in transgenic mice, with expression of the gene properly restricted to juxtaglomerular cells in the kidney. Furthermore, we demonstrate that human renin expression in the kidney responds to the release of angiotensin 11-mediated feedback repression caused by inhibition of angiotensin converting enzyme and that active human renin is released into the systemic circulation. We will discuss the implications for mapping relevant cis-acting regulatory elements in the human renin gene.
Materials and Methods Generation of Transgenic Mice
The transgene used herein consists of a human renin genomic clone extending approximately 900 bp upstream and 400 bp downstream of the coding region cloned into the bacterial vector pUC8 using Bgl II linkers and was the kind gift of Dr. V. Dzau, Stanford University. This segment contains all 10 exons (I-IX, VA) and all intervening intron sequences. Before microinjection the human renin portion of the clone was purified away from the vector sequences by Bgl II digestion and agarose gel electrophoresis. The DNA fragment was excised and cleaned for microinjection using Geneclean (BiolO1). The resultant fragment (-13 kb) was microinjected into fertilized one-cell embryos derived from C57BL/lORos xC3H/HeRos (BCF2 mice) at a concentration of 1.0 ,ug/ml. Transgenic mice were constructed as previously described.29,30 All mice were fed standard mouse chow and water ad libitum. For captopril treatment, the inhibitor was administered in drinking water (100 mg/kg per day) for 5 days before the mice were killed. Previous studies have shown this treatment to be highly effective in increasing renal renin mRNA accumulation in mice fivefold to 10-fold.3031 Care of the mice used in these experiments met or exceeded the standards set forth by the National Institutes of Health in their guidelines for the care and use of experimental animals. Procedures used were approved by the Institute Animal Care and Use Committee (Roswell Park Cancer Institute) and the University Animal Care and Use Committee (University of Iowa).
Analysis of Nucleic Acids
Genomic DNA was purified from tail biopsies29 and was subjected to Southern blot analysis32 to identify founder animals. Genomic DNA was digested with BamHI, and blots were probed with an internal 2.1-kb genomic BamHI fragment encompassing exons III-V (data not shown). Once transgenic lines were established, positive transgenics were differentiated from negative littermates using a dot blot manifold. Dot blots were probed with a partial 642 bp Sst I-EcoRI cDNA fragment encompassing exons VI-IX.
All tissues were completely removed from surrounding.adipose tissue by either removing the capsule surrounding the tissue or by fine dissection under a microscope. Total tissue RNA was isolated and purified by homogenization in guanidine isothiocyanate followed by ultracentrifugation through a cesium chloride pad as RNase blot protection was developed to rapidly assess the relative expression of the human renin gene and to differentiate human renin mRNA from the endogenous renin mRNA in tissues where both are coexpressed. In this assay, total tissue RNA is fractionated by electrophoresis through a 1.5% agarose-formaldehyde gel and transferred to nitrocellulose as previously described. 33 Blots were then probed with either a human renin or mouse renin (Ren-2) antisense RNA probe. The Ren-2 clone (pSLM) used to generate the antisense RNA has been previously described.2834 The human renin clone contains a portion of the cDNA spanning a region from the EcoRI site at coordinates 741 to an Sst I site at coordinates 1,383 of the cDNA sequence and encompassing exons VI-IX cloned into pGEM-3 (Promega Corp., Madison, Wis.). Labeled antisense RNA is generated from both these clones with the use of SP6 polymerase (Bethesda Research Laboratory) and 50 ,uCi [a-32P]GTP. The blots were probed under standard conditions20,35 and exposed to x-ray film. Since the mouse and human renin messages share approximately 80% identity, either probe will detect the combined human plus mouse renin mRNA in a single tissue. To differentiate the mRNAs, the blots were washed in 2 x standard saline citrate containing 1.0 gg/ml RNase A for 15 minutes at 25°C followed by a stringent wash in 0.1x standard saline citrate, 0.1% sodium dodecyl sulfate for 20 minutes at 65°C. This treatment destroys the hybridization between an RNA probe and an RNA immobilized on a filter when they exhibit a large number of mismatches, because, in essence, the RNase treatment reduces the long uninterrupted probe to short oligonucleotides, which are easily washed away by a low salt stringent wash. However, the perfect duplex formed by the species-specific interaction between probe and mRNA protects it from the RNase treatment. Under these conditions 95% of the mRNA detected with the mouse probe is endogenous mouse renin mRNA (not shown), whereas approximately 90% of the sequences detected using the human probe is human renin mRNA (see Figure 2 for an example).
The differential primer extension assay is based on a modification of the assay described by Field and Gross.36 In this assay, total RNA is hybridized to an end-labeled 37-base oligonucleotide (5'-GACTT-TGAAGGTCTGGGGTGGGGTGCCGATGC-CAATC-3') derived from the human sequence by incubation of 200 ng oligonucleotide with T4 polynucleotide kinase and 100 ,uCi [y-32P]ATP. This oligonucleotide shares 36 of 37 bases in common with the mouse sequence and hybridizes equally well to both the human and mouse renin mRNA (not shown). The hybrids are then used as a template for primer extension by incubating them in the presence of avian myeloblastosis virus reverse transcriptase; 200 ,uM dCTP, dGTP, and TTP; and 200 ,M of the chain-terminating nucleotide ddATP. The buffers and incubation conditions have been described previously.36 This incubation results in differentially truncated nucleotide chains of 43 and 45 bases in length. The human product is 43 bases in length because the ddATP is inserted complementary to the U in the mRNA at position 43. The mouse sequence, however, contains a C in the mRNA at position 43; consequently, the chain continues to grow until it described.33 reaches the U in the mRNA two bases further downstream, at position 45 ( Figure 5A ). These products are separated from the unextended oligonucleotide on an 8% acrylamide/8 M urea sequencing gel. Primer extension products were quantitated by excising gel slices and Cerenkov counting. Samples were normalized for equal loading by comparing the counts in the unextended oligonucleotide band.
In Situ Hybridization
Tissues were removed and immediately frozen in isopentane at -700C. Frozen sections were cut 8 gm thick and were hybridized to an antisense human renin SP6 RNA probe labeled with 35S-UTP as previously described.2834 The specificity of the hybridization was tested using a sense orientation probe (not shown). The RNase A incubation after the hybridization allowed us to favor the detection of human renin-specific mRNAs but did not totally eliminate hybridization to nontransgenic kidney, demonstrating that the differentiation between the mouse and human mRNAs was not 100% efficient. Nevertheless, hybridization to human renin transcripts was strongly favored. Additionally, it is important to note that these experiments were performed on kidney tissue from transgenic line 8, a line in which transcription of the human renin gene slightly exceeded that of the endogenous mouse gene as determined by differential primer extension ( Figure 5 ). All these factors taken together strongly suggest that substantially greater than 50% of the hybridization signal we observed represents human renin mRNA.
Since these transgenic mice were produced from a genetic background that does not express adrenal renin in adults,1 28 the hybridization signal obtained on transgenic adrenal sections was exclusively human renin. A Ren-2 antisense probe was used for in situ hybridization on DBA/2Ros adrenal gland as previously described.28
Plasma Renin Activity Assay
Plasma renin activity (PRA) determinations were performed using a clinical assays kit with a modification of the protocol suggested by the manufacturer (Baxter Health Care Corp., Cambridge, Mass.). This kit has been previously used to accurately determine the PRA of mice.30 Blood samples were withdrawn from transgenic mice and their negative age-matched littermates by orbital eye bleed under light ether anesthesia. Blood was collected into ice-cold microcentrifuge tubes containing EDTA using non-heparin-coated glass pipettes and was immediately centrifuged to isolate plasma. Plasma was stored at -70°C until needed. Each sample was frozen and thawed only once. Ten microliters of phenylmethylsulfonyl fluoride solution and 15 gl maleate generation buffer (both supplied with the kit) were added to a thawed 150-gl aliquot of plasma. This reaction mixture was divided into three tubes: 1) 50 gl was removed and incubated on ice to serve as a negative angiotensin I generation control; 2) 50 gil was removed to a second tube, and 1 ug synthetic human renin substrate tetradecapeptide (Sigma Chemical Co., St. Louis, Mo.) was added; and 3) 50 gI was removed to a third tube but left unaltered. Tubes 2 and 3 were incubated at 37°C for 90 minutes. At the end of the incubation. the samples were all placed on ice. For radioimmunoassay, 5 and 45 gl of the reaction mixtures were added to the antibody-coated tubes supplied with the kit. Tracer addition and radioimmunoassay were then performed as described by the manufacturer (Baxter). There was no significant detection of the excess human tetradecapeptide by the radioimmunoassay (data not shown). Results
Identification of Transgenic Mice
Transgenic mice containing a human renin gene were constructed to examine the regulation of the tissueand cell-specific expression of the gene in vivo. For these experiments, a genomic segment containing all exon and intron sequences along with flanking sequences extending approximately 900 bp upstream (5 flanking sequence) and 400 bp downstream (3' flanking sequence) was used. A schematic representation of the transgene is shown in Figure 1A . Positive transgenic founder mice were identified by Southern blot analysis (not shown), and positive transgenic offspring were routinely differentiated from nontransgenic littermates by dot blot hybridization ( Figure 1B) . When transgenic males of lines 7, 8, and 10 were bred to nontransgenic females, approximately 50% of the offspring were transgenic, and these were equally divided among males and females, indicating Mendelian autosomal inheritance of the transgene. However, in transgenic line 9, 56 of 56 female and zero of 37 male progeny of a male transgenic-by-female nontransgenic cross were positive, indicating that the transgene in this line integrated into the X chromosome and exhibited a sex-linked mode of inheritance. Tissue-Specific Expression of the Human Renin Transgene Standard Northern blot analysis was not sufficient to completely differentiate between the two species of mRNA in tissues in which both messages were coexpressed because of the cross-reactivity of the cDNA probes. Consequently, two assays were developed to differentiate between the human and murine renin mRNAs. The first assay, termed RNase blot protection, is a modification of the standard Northern blot protocol and is illustrated schematically in Figure 2A and described in "Materials and Methods."
The tissue specificity of human renin expression was addressed by examining the steady-state accumulation of its mRNA in the adrenal gland, kidney, submandibular gland, testis, liver, ovary, brain, lung, heart, and adipose tissue. Figure 2B shows the results of RNase blot analysis on total adrenal RNAs from several transgenic mice, nontransgenic DBA/2Ros mice, which express two endogenous mouse renin genes in the adult adrenal (Ren-ld and Ren-2), and nontransgenic BCF, mice, which contain the Ren-lc gene but do not express it in the adult adrenal gland.' These transgenic mice were constructed on the BCF genetic background so that the hybridization signal obtained from the transgenic adrenal gland should be exclusively human. Before the RNase treatment, approximately equal hybridization intensity could be seen in the transgenic and nontransgenic DBA adrenal samples ( Figure 2B, top) . No renin mRNA was detected in the nontransgenic BCF sample. After the RNase treatment, a strong hybridization signal was still evident in the transgenic samples but not in the nontransgenic sample ( Figure  2B , bottom). Figure 3 shows a representative RNase blot analysis of kidney, submandibular gland, testis, and liver RNA from a nontransgenic and two transgenic mice. Even before the RNase treatment, it is clear that the hybridization signal is more intense in the transgenic kidney and testis and that neither renin gene is expressed in the liver (top blot). After the RNase treatment, there is clear evidence of human renin expression in the kidney and testis of both transgenic lines and in the submandibular gland of one transgenic line (bottom blot). Note that the hybridization signal from these tissues is clearly above the background obtained from the nontransgenic control. Easily detectable expression of human renin is also evident in the ovary, lung, and adipose tissue of all lines (Figure 4 ). No detectable human renin mRNA was evident in the liver or brain of any transgenic line. A summary of these results is presented in Table 1 .
To experimentally verify that the hybridization signals obtained above arose from expression of a bona fide human renin gene and to quantitate the relative level of human renin transgene expression, differential primer extension was performed (see "Materials and Methods"). Total kidney RNA from several transgenic lines and from a nontransgenic control was analyzed by primer extension (Figure 5B) . The renin genes in the kidney. Quantitation of these results demonstrated that the human and mouse renin genes are nearly equivalently expressed in the transgenic kidney. We also confirmed the exclusive expression of the human renin gene in the adrenal glands of transgenic mice ( Figure 5C ) and firmly established the expression of the human renin gene in testis, ovary, lung, and adipose tissue ( Figure SD) . Primer extension was also used to verify the unique expression of human renin mRNA in the submandibular gland of line 10 ( Figure 5D ).
Cell Specificity of Human Renin Expression in the Kidney and Adrenal Gland
The cell specificity of human renin expression was examined in the kidney and adrenal gland by in situ hybridization using an antisense human renin cDNA fragment as probe. In the adult kidney, renin expression is highly restricted to juxtaglomerular cells, which are modified smooth muscle cells lining the afferent arteriole near the glomerular hilus. Figure 6 shows the in situ hybridization pattern for human renin mRNA in the kidney from an adult line 8 mouse. Histological staining clearly shows the presence of three glomeruli in the field (closed arrowheads) along with autoradiographic grains in the juxtaglomerular areas of each (open arrowheads). The dark field image ( Figure 6B ) shows the lack of autoradiographic grains in any other portion of the field except the juxtaglomerular area, clearly demonstrating the cell specificity of human renin expression in the kidney.
We were particularly interested in determining the cell specificity of human renin in the adrenal gland because of the reported species specificity of adrenal renin expression. It is now well documented that renin expression in the adrenal gland of DBA mice is localized to two inner cortical zones known as the zona fasciculata and X zone ( Figure 6 ).28 However, the localization of renin mRNA in the adrenal glands of rats has been reported to occur in the outermost cortical zone, the zona glomerulosa. 27 In situ hybridization was performed on adrenal glands from two female transgenic mice (line 8) that were killed at either metestrus (Figures 7C and 7D ) or estrus (Figures 7E and 7F) . No evidence of human renin expression was detected in the zona fasciculata or X zone. Expression of the human renin gene was often visible in the adrenal capsule and associated connective tissue ( Figure 7F ). On occasional sections, the autoradiographic grains appeared to be present within the parenchyma of the gland as clusters of cells in the outer cortex, presumably the zona glomerulosa ( Figures 7D and 7F , open arrowheads). The number of positive clusters per section was highly variable, and they were not visible in all histological sections. There was no apparent difference in adrenal renin expression between estrus or metestrus. It will be interesting to determine the pattern of adrenal renin expression at different stages of the estrus cycle in transgenic line 9, which has the transgene integrated into the X chromosome. No hybridization was detected in the nontransgenic adrenal gland.
Regulated Renal Expression and Release of Human Renin
Transgenic and nontransgenic mice from lines 8-10 were treated with the angiotensin converting enzyme inhibitor captopril in their drinking water for 5 days (100 mg/kg per day). This treatment results in the inhibition of angiotensin II formation and relieves angiotensin IT-mediated feedback repression of renin expression in the kidney. This generally results in a fivefold to 10-fold induction of renal renin mRNA accumulation.30,3' Total kidney RNA from treated and untreated mice was subjected to differential primer extension (Figure 8 ). Captopril treatment induces increased endogenous renin mRNA accumulation in nontransgenic and transgenic mice (compare untreated and treated pairs of mice). In addition, expression of the . BCF mice do not express renin in the adult adrenal gland. DBA mice express the Ren-1d gene and the Ren-2 gene, but only Ren-1d is detected. Because ofsequence differences between the mouse renin genes, the Ren-2product would give the same extension as the human renin gene. However, the Ren-2 gene exhibits three mismatches with the 37-base oligonucleotide in the 3' half of the sequence and thus destabilizes any hybrids that would form. Panel D: P.E. analysis of RNA from testis (T, 80 pg), submandibular gland (S, 80 pg), lung (L, 30 gg), ovary (0, 20 pg), and adipose tissue (A, 10 pg) from the indicated transgenic mice (lines 8-10) or nontransgenic mice (-). The positions of the human-specific and mouse-specific products are indicated.
human renin gene was also induced in all three transgenie lines after captopril treatment. The level of induction varied for both the endogenous and human renin gene from line to line (Table 1 ) but was generally fivefold to ninefold for the endogenous gene and approximately twofold for the human renin gene. The difference in induction between the mouse and human gene remains unclear.
A PRA assay was performed to determine whether active human renin protein was being released into the systemic circulation. Under assay conditions in which the endogenous mouse substrate (angiotensinogen) was used, there was no significant difference in PRA between transgenic mice and control mice ( Figure 9A ). Since the renin-angiotensinogen reaction exhibits a strict species specificity,37,38 it was anticipated that human renin would not cleave mouse substrate, although it may do so with greatly reduced kinetics. This is an important control in that it demonstrates that the levels of active mouse renin (renin-1 isozyme) are not significantly different between transgenic and control mice. When the assay was repeated with the inclusion of 1 gg synthetic human renin substrate (tetradecapeptide), a significant increase in PRA was observed for both transgenic and nontransgenic mice ( Figure 9B ). Both mouse renin and human renin have the ability to cleave low molecular weight synthetic substrates37; therefore, the activity measured in the transgenic group is the combined effect of active mouse and human renin.
Nevertheless, there was a significant elevation ir. PRA in the transgenic mice as compared with their negative littermate control group (p<0.007). Extrapolating for the contribution of mouse renin present in the transgenic plasma (transgenic PRA-nontransgenic PRA) revealed that approximately equal levels of active mouse and human renin are released into the systemic circu- lation, a finding completely consistent with the relative levels of specific renal renin mRNAs ( Figure 5B ).
Discussion

Tissue-and Cell-Specific Expression
Human renin protein has been detected in a number of human tissues on the basis of its activity or by immunohistochemical analysis.2 14 However, experiments examining the localization of renin mRNA have been hampered by the need for fresh human tissues for RNA analysis. Indeed, the demonstration of primary renin expression in these tissues is necessary to rule out the possibility of renin uptake. Transgenic mice provide a unique opportunity to examine the expression of the human renin gene in experimentally manipulatable animals without the need for human tissues. The two assays described herein when used in concert provide a powerful tool to differentiate and quantitate the relative expression of human and mouse renin mRNAs and thus afford an advantage over a previous report in which the relative transgene expression level could not be assessed. 39 Moreover, transgenic studies are particularly important because of the paucity of adequate reninexpressing cell lines available for in vitro studies.
We have shown that a human renin transgene consisting of approximately 900 bp of the 5' flanking sequence, all exons and introns, and approximately 400 bp of the 3' flanking sequence is expressed in a tissueand cell-specific manner in transgenic mice. All lines tested expressed human renin mRNA qualitatively similar in kidney, adrenal gland, testis, and ovary, each of which is a normal site of renin expression in rodents.3 '15 At the cellular level we confirmed the restricted expression of renal renin to juxtaglomerular cells, which make up approximately 0.01-0.1% of the total cellular mass of the kidney (Figure 6 ). In adult transgenic mice, human renin expression in the kidney was stimulated by captopril treatment (Figure 8 ). Therefore, we can conclude that this transgene contains all the sequences required for properly regulated tissue-and cell-specific expression of human renin in the kidney.
In the adrenal gland, human renin mRNA was detected in the adrenal capsule and adjoining connective tissue as well as in some cells in the zona glomerulosa (Figure 7) . Expression in the zona glomerulosa contrasts with the normal cellular localization of renin mRNA in the mouse adrenal gland28 but reflects the localization of renin mRNA reported for the rat and human adrenal gland.727 Perhaps the human renin gene or two transgenic mice (line 8) (panels C-F) were hybridized in situ with a murine renin probe (panels A and B) or human renin probe (panels C-F). There is no expression of the murine renin gene in the transgenic adrenal gland. contains distinct sequence elements conferring expression in this zone, elements that may be discrete from those that impart inner cortical (zona fasciculata and X zone) expression on the murine renin genes. Importantly, since some mouse zona glomerulosa cells had the capacity to express human renin, the regulatory factors that play a role in this process may be evolutionarily conserved. It is presently unclear why expression of human renin was restricted to widely scattered pockets of cells and not evenly distributed throughout the zone. Expression of the rat renin gene in the adrenal gland is regulated by dietary sodium40 and increased after nephrectomy.41 Perhaps such strong inducing stimuli will cause a recruitment of other zona glomerulosa cells to produce human renin. Human renin mRNA was also detected in the submandibular gland and heart of individual transgenic lines and in the lung and adipose tissue of all transgenic lines tested. The submandibular gland is a bona fide source of renin mRNA in the mouse. 36 However, there is no evidence for renin in the rat submandibular gland.22 '26 In previous studies using transgenic mice, Fukamizo and colleagues39'42 reported the expression of a human renin transgene extending 3.0 kb in the 5' direction and 1.2 kb in the 3' direction in a number of tissues including the heart and lung. The heart has been proposed to contain a tissue renin-angiotensin system,18 and components of the renin-angiotensin system including renin mRNA have been reported in the heart.43-45 Nevertheless, it is important to note that this observation is controversial, and many investigators have failed to detect renin mRNA in the heart. Renin has been reported in human fetal lung and human pulmonary tumors.46,47 Although renin has not been previously detected in adipose tissue, it is interesting to note that angiotensinogen, the substrate of renin, is expressed in adipose tissue and in cell lines that can be induced to differentiate into adipocytes. 48, 49 There are several possible explanations we can offer to reconcile the expression we observed in the submandibular gland, heart, lung, and fat. First, the expression of human renin in these tissues is the result of chromosomal position effects on transgene expression. By definition, such artifacts are those seen in individual transgenic lines that are due to the unique site of transgene insertion exhibited by different founder mice. Expression of human renin in the heart and submandibular gland may meet this definition. Second, abnormal quantitative expression of transgenes in certain tissues has been reported even when they exhibit proper qualitative expression28; i.e., although the expression of a transgene is restricted to the correct spectrum of tissues, its level of expression in these tissues may be higher or lower than normal. Therefore, the expression we detect in these tissues, although greatly exaggerated in transgenic mice, may be a true representation of human renin expression in humans. Last, it remains possible that the expression of human renin in some of these tissues is merely ectopic, i.e., expressed at sites at which it is not normally expressed in humans. This may result if the transgene used contains an amount of regulatory information insufficient to confer a completely restricted tissue-specific expression profile (see below).
Regulation of Human Renin Transcription
Our results indicate that sequences necessary for regulated tissue-and cell-specific expression of the human renin gene in most tissues lie within the 900 bp 5'structural gene-400 bp 3' DNA segment. The sequences controlling tissue-specific expression are generally located in the 5' flanking region of a gene, although some genes contain important regulatory information in introns and in the 3' flanking region of the gene.50'51 Indeed our transgene is significantly shorter at both the 5' and 3' ends than the one used by Fukamizo et al,39 who reported a similar, but not identical, pattern of human renin mRNA in transgenic mice. Nevertheless, we cannot conclusively show at this time that sequences between -3.0 kb and -900 bp are dispensable for expression. In fact, evidence from the expression of the murine renin genes would suggest that additional 5' regulatory information may be required when those sequences are dissected away from the body of the structural gene. Although a murine Ren-2 construct containing 2.5 kb of the 5' flanking region is sufficient to confer tissue specificity when in its normal genomic context,52 the same 25-kb region cannot confer the same specificity on its own when fused to a reporter gene. 53 However, a fusion containing 4.6 kb of Ren-2 5' flanking sequence can confer both tissue and cell specificity when fused to the same reporter. 35 These results imply that sequences close to the gene, although important for tissue specificity, may not be sufficient in the absence of sequences either further upstream or within the body of the gene itself. It also suggests the possibility of redundancy in regulatory elements in the 5' flanking region and within the gene. 15 Whether the same redundancy in regulatory elements is present in the human renin gene will need to be determined experimentally. It is likely that there will be some similarity between regulatory elements in renin genes across species. With the notable exceptions discussed earlier, the tissue specificity of renin across species boundaries is conserved. An analysis of the 5' flanking region of mouse, rat, and human renin genes has revealed several blocks of highly conserved sequence, and it is likely that these conserved blocks encode some of the important regulatory elements.54
